childless vs those with children, bilateral VV performed in 74% vs 66%, bilateral VE performed in 10% vs 12% and combination VV/VE in 13% vs 16%; these differences were not significant. Patency was 98% (n¼102) for childless men and 94% (n¼949) for men with prior children.
INTRODUCTION AND OBJECTIVES: Approximately 20% of men who undergo vasectomy subsequently consider reversal. However, the factors influencing the decision to undergo vasectomy reversal (VR) after vasectomy are poorly understood. Here we examine the characteristics and motivating factors of men who expressed preliminary interest in and subsequently elected to proceed or not to proceed with VR.
METHODS: Between February 2011 and October 2016, 252 men inquired about VR from a single andrology clinic through its website. These men were emailed an electronic survey assessing demographic information and motivations for VR. T-test of means and Chisquare test were used to analyze the data.
RESULTS: The survey was completed by 45 (17.8%) of the 252 men. The mean(SD) time since vasectomy was 9.8(7.7) years, and number of children was 2.2(1.1). One half (49%) of the respondents had undergone VR with an average of 9.7 years between vasectomy and VR. Table 1 compares factors associated with decision to proceed with VR after initial inquiry. Men with an annual income >$100,000 and with at least a college degree were more likely to undergo VR, while time since vasectomy, number of children, age of current partner, and having a new partner following vasectomy did not influence the decision to proceed. Reasons to forego VR included cost (48%), lack of interest in having children (26%), lack of time (9%), and lack of information about the procedure (9%). Most (74%) men who did not undergo VR plan to pursue VR in the future and reported that speaking to another patient (26%), a brochure (30%), and talking to a doctor (39%) would assist their decision making.
CONCLUSIONS: After initial interest in VR following vasectomy, men with high incomes and education are more likely to undergo VR. Financial burden was the most common reason preventing VR. Most men who did not undergo VR reported continued interest in VR and that receiving additional information would assist their decision making. Ethan Grober*, Sammi Tobe, Toronto, Canada INTRODUCTION AND OBJECTIVES: During vasectomy reversal (VR), intra-operative microscopic evaluation of the vasal fluid for sperm presence and quality can inform of the possibility of epididymal obstruction and need for a vasoepididymostomy (VE). Despite its potential utility, the practice of intra-operative microscopic vas fluid evaluation is not universal. Some centers may not have bench microscopy available. Some surgeons may only perform vasovasostomy (VV) and therefore are not influenced by vasal fluid characteristics or alternatively feel that the vasal fluid quality alone can predict the need for a VE. Objective: In an effort to validate the utility of microscopic vasal fluid evaluation, the current initiative correlates vasal fluid characteristics with sperm presence and quality in a large series of VRs.
Source of
METHODS: 1108 bilateral vasectomy reversals performed by a single surgeon (EG) yielded a total of 2216 vasal units (right & left sides) for analysis. During VR, vasal fluid was expressed and sampled from the transected testicular end vas and the fluid was characterized (thickpaste/opaque/translucent/clear). The volume of vasal fluid was documented (copious/minimal). Each aspirated sample underwent microscopic evaluation for sperm quality and categorized as: motile sperm/ intact non-motile sperm/sperm parts/no sperm. The predictive utility of the gross vasal fluid characteristics with respect to sperm presence and quality was analyzed.
RESULTS: Table 1 summarizes the relationship between the gross vasal fluid characteristics and the microscopic presence and quality of sperm within the fluid among 2216 vasal units. When thickpasty fluid was observed, no sperm were seen in the samples in 50% of cases and if present, only non-motile sperm were observed. Importantly, even in the setting of more favorable vasal fluid characteristics (clear, translucent & opaque fluid), no sperm were seen in 7-11% of cases, suggesting the possibility of epididymal obstruction and the need for a VE.
CONCLUSIONS: Intra-operative microscopic evaluation of the vasal fluid for sperm is a necessary practice during vasectomy reversal to optimize surgical outcomes. The gross characteristics of the vasal fluid alone does not universally predict sperm presence and quality. Reliance on vasal fluid characteristics in isolation, without microscopic sperm analysis, may lead to unrecognized epididymal obstruction and the possible need for a VE in approximately 10% of cases of VR. 197, No. 4S, Supplement, Tuesday, May 16, 2017 as well as resident and fellow surgical assistance were documented. Patient and female partner age, natural pregnancy rates, procedure type, pre-and post-operative semen parameters, time from vasectomy, and postoperative complications were all evaluated. The effects of a fellow surgical assistance on perioperative and postoperative outcomes were then analyzed. Statistical significance, defined as a p-value <0.05, was determined using Student's T, chi square or Fischer exact test. RESULTS: We identified 183 patients who underwent subinguinal varicocele ligation or vasectomy reversal by a single surgeon at our institution. All patients undergoing surgery for fertility concerns were included for analysis. Vasectomy reversals requiring one or more vasoepididymostomy were excluded from analysis, due to insufficient numbers for meaningful comparison, as were any patients undergoing combined cases in addition to microsurgical surgery. Compared to when faculty was operating without a fellow (n¼72), fellow surgical assistance (n¼81) results in a statistically significant prolonged operative time for both unilateral varicocele ligation (1:22 vs 1:01, p<0.01), bilateral varicocele ligation (2:13 vs 1:43, p<0.01), and bilateral vasovasostomy (2:49 vs 2:19, p<0.01). Comparing fellow assisted cases to those without a fellow, there were no significant differences in all other outcome measurements or patient demographics. Overall, 69.0% of patients undergoing varicocelectomy experienced a significant improvement in their Total Motile Sperm Count post-operatively, and 100% of patients achieved patency after vasectomy reversal.
Source of Funding: None
CONCLUSIONS: Fellowship training was associated with ã 30% increase in operative time for unilateral and bilateral varicocele ligation, and a~20% increase in operative time for bilateral vasovasostomy, but does not adversely impact outcomes of microsurgical cases.

MP89-19 TIMING OF RETURN OF SPERM TO THE EJACULATE AND LATE FAILURES FOLLOWING VASAL RECONSTRUCTION
Ryan Flannigan*, New York , NY; Phil V. Bach, New York, NY; Abimbola Ayangbesan, Andrew Gottesdiener, Marc Goldstein, New York , NY INTRODUCTION AND OBJECTIVES: Vasal reconstruction is an effective method of treating obstructive azoospermia, with reported patency rates of 99% for vasovasostomy (VV) and 80% for vasoepididymostomy (VE). When deciding between sperm retrieval with in vitro fertilization or vasal reconstruction, a major consideration is often the length of time it will take for sperm to return to the ejaculate following vasal reconstruction. The objective of this study was to compare the time required for sperm to return to the ejaculate following VV or VE, and if the rate of late failures would be less common in VV compared to VE.
METHODS: We performed a retrospective review of all patients undergoing VV and VE by a single surgeon. Demographic information, surgical details, and postoperative semen analysis (SA) values and dates were reviewed. Late failures were defined as those with sperm return to the ejaculate post-reconstruction who subsequently became azoospermic. Descriptive statistics, student t-test, and Fishers exact tests were used to compare the groups, with significance set at p<0.05.
RESULTS: 338 and 37 men underwent VV and VE, respectively, and had sperm return to the ejaculate postoperatively. Mean age was 43+/-6.7 years, with a mean obstructive period of 10+/-5.5 years. Mean time to return of sperm in the ejaculate was faster following VV than after VE (Table 1) . Initial sperm counts were also higher following VV compared to VE (Table 1) . Longitudinally, more men had late failure of vasal reconstruction after VE than after VV (Table 1) . Presence of sperm granuloma did not impact time to return of sperm in the ejaculate (p¼0.22) after VV. Obstructive interval was not associated with either sperm count in the ejaculate after vasal reconstruction or time to return of sperm to the ejaculate. CONCLUSIONS: Among men undergoing vasal reconstruction, return of sperm to the ejaculate typically occurs at 3 months after VV and at 5 months after VE. A small, but significant, proportion of men undergoing vasal reconstruction will have late failures, especially after VE. Since these late failures typically occur within one year postoperatively, men undergoing vasal reconstruction should be advised to consider sperm cryopreservation as soon as motile sperm appear in the ejaculate. 
Source of Funding: Frederick J and Theresa Dow Wallace
INTRODUCTION AND OBJECTIVES:
Microsurgical denervation of the spermatic cord (MDSC) is a treatment option for chronic scrotal content pain that is unresponsive to conservative treatments. A recent study has shown specific nerve fiber abnormalities (Wallerian degeneration) in the cord as a potential cause for this pain. Our goal was to assess outcomes of a more targeted technique in ablating only these abnormal nerves when performing MDSC: targeted robotic assisted microsurgical denervation of the spermatic cord (RMDSC).
METHODS: Retrospective review of 772 patients who underwent RMDSC by two fellowship trained microsurgeons from October 2008 to July 2016. Selection criteria were as follows: chronic testicular pain (>3 months), failed standard pain management treatments and negative urologic workup. Targeted ligation of tissues containing the trifecta location of nerves with Wallerian degeneration was performed: the cremasteric muscle fibers, the peri-vasal sheath and the posterior spermatic cord lipomatous tissues. The primary outcome measure was level of pain. Pain was assessed preoperatively and postoperatively using two assessment tools: a) the subjective visual analog scale (VAS) and b) an objective standardized externally validated pain assessment tool (PIQ-6, QualityMetric Inc., Lincoln, RI).
RESULTS: Median age was 41 years. Median operative duration (robot console time) was 20 minutes (15-80). Median follow up was 24 months. Subjective VAS patient pain outcomes: 84% significant reduction in pain (50% complete resolution e 425 patients, 34% reported a greater than 50% reduction in pain e 291 patients). Objective PIQ-6 outcomes: significant reduction in pain in 67% of patients at 6 months and 68% at 1 year post-op.
CONCLUSIONS: Targeted robotic assisted microsurgical denervation of the spermatic cord is a safe and viable treatment option for patients with chronic scrotal content pain refractory to conservative measures. Further studies are warranted.
